Intravenous linezolid administered orally: A novel desensitization strategy

Pharmacotherapy

Volumn 26, Issue 4, 2006, Pages 563-568

  Cawley, Michael J ^a   Lipka, Ozana ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

Desensitization; Enterococcus faecium bacteremia; Hypersensitivity; IgE; Immunoglobulin E; Linezolid; Multidrug resistance; Myasthenia gravis; Oxazolidinone

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; IMMUNOGLOBULIN E; LINEZOLID; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CASE REPORT; DESENSITIZATION; DOSE RESPONSE; DYSPNEA; ENTEROCOCCUS FAECIUM; FEMALE; FEVER; HUMAN; HYPERSENSITIVITY REACTION; MINIMUM INHIBITORY CONCENTRATION; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; NAUSEA; PTOSIS; VASCULAR ACCESS; VOMITING;

ACETAMIDES; ADMINISTRATION, ORAL; ADULT; ANTI-INFECTIVE AGENTS; DESENSITIZATION, IMMUNOLOGIC; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; FEMALE; HUMANS; MYASTHENIA GRAVIS; OXAZOLIDINONES;

EID: 33645688887     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.4.563     Document Type: Article

References (24)

1. Daly JS, Elipoulos GM, Willy S, Moellering RC Jr. Mechanism of action and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob Agents Chemother 1988;32:1341-6.
2. Pharmacia and Upjohn, Division of Pfizer, Inc. Data on file. New York, NY; March 2005.
3. Rybak MJ, Hershberger E, Moldovan T, Grucz RG. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and resistant strains. Antimicrob Agents Chemother 2000;44:1062-6.
4. Cercenado E, Cercenado S, Gomez JA, Bouza E. In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides. J Antimicrob Chemother 2003;52:138-9.
5. Coombs R, Gell PGH. Classification of allergic reactions responsible for clinical hypersensitivity and disease. In: Gell P, Coombs RRA, Lachman PJ, eds. Clinical aspects of immunology. Oxford, England: Blackwell Scientific, 1975:761-81.
6. Patterson R, DeSwarte RD, Greenberger PA, Grammer LC. Drug allergy and protocols for management of drug allergies. N Engl Reg Allergy Proc 1986;7:325-42.
7. Borish L, Tamir R, Rowenwasser LJ. Intravenous desensitization to beta-lactam antibiotics. J Allergy Clin Immunol 1987;80:314-19.
8. Sullivan TJ, Yecies LD, Shatz GS, Parker CW, Wedner JH. Desensitization of patients allergic to penicillin using oral administrated β-lactam antibiotics. J Allergy Clin Immunol 1982;69:275-82.
9. Cortese LM, Soucy DM, Endy TP. Trimethoprim/sulfamethoxazole desensitization. Ann Pharmacother 1996;30:184-6.
10. Lin RY. Desensitization in the management of vancomycin hypersensitivity. Arch Intern Med 1990;150:2197-8.
11. Stark BJ, Earl HS, Gross GN, Lumry WR, Goodman EL, Sullivan TJ. Acute and chronic desensitization of penicillin-allergic patients using oral penicillin. J Allergy Clin Immunol 1987;79:523-32.
12. Tidwell BH, Cleary JD, Lorenz KR. Antimicrobial desensitization: a review of published protocols. Hosp Pharm 1997;32:1362-9.
13. Earl HS, Sullivan TJ. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol 1987;79:477-83.
14. Chegini S, Hagaman D, Holland S. Linezolid hypersensitivity: an intravenous (IV) desensitization protocol [abstr]. Fed Am Soc Exp Biol 2000;14:198.12.
15. Sullivan TJ. Allergic reactions to antimicrobial agents: a review of reactions to drugs not in the beta lactam antibiotic class. J Allergy Clin Immunol 1984;74:594-9.
16. Gruchalla R. Understanding drug allergies. J Allergy Clin Immunol 2000;105:S637-44.
17. Gruchella RS, Pesenko RD, Do TT, Skiest DJ. Sulfonamide-induced reactions in desensitized patients with AIDS: the role of covalent protein haptenation by sulfamethoxazole. J Allergy Clin Immunol 1998;101:371-8.
18. Pharmacia and Upjohn, Division of Pfizer, Inc. Zyvox (linezolid) package insert. New York, NY; 2005.
19. Weiss ME, Adkinson NF Jr. β-Lactam allergy. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practices of infectious diseases. Philadelphia, PA: Churchill Livingstone, 2005:318-26.
20. Turvey SE, Cronin B, Arnold AD, Dioun AF. Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Ann Allergy Asthma Immunol 2004;92:426-32.
21. Nordenberg T. Inside FDA: when a drug is in short supply. FDA Consumer 1997;31(7):30-2.
22. Vecchione A. Drug shortages: industry copes as it waits for supplies. Hosp Pharm Rep 1997;11:1, 7.
23. Nelson RE, Biderdorf RI. Nationwide drug shortages: it's time to take the lead. Nutr Clin Pract 1998;13:295-7.
24. ASHP Council on Administrative Affairs, American Society of Health-System Pharmacists. ASHP guidelines on managing drug product shortages. Am J Health-Syst Pharm 2001;58:1445-50.